Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
The Biden administration announced that it is awarding grants to Regeneron, Johnson & Johnson and other leading medical researchers to develop therapeutics to "protect against COVID-19 for years to come," according to the HHS.
The German pharma giant is the latest company to sue the feds over the new Medicare plan, leaving many industry experts wondering if this fight is headed to the Supreme Court.
Both health facilities may be in violation of the Minnesota Hospital Agreement, which protects patients from abusive, harassing and deceptive practices when hospitals seek to collect medical debt, according to the state's attorney general.
A federal appeals court has reinstated a lawsuit against Walgreens for violating the federal False Claims Act by improperly receiving hundreds of thousands of dollars from Virginia's Medicaid program.
As lawmakers scrutinize the nation's pharmacy benefit managers, the California insurer expects to save $500 million in annual drug costs by replacing most of CVS Health's PBM services by January 2025.
Weeks before the CMS is releasing a list of drugs eligible for price negotiations, the Justice Department filed a motion, contesting the Chamber's move to block the program, claiming the pause would harm the public.
Following Biden's $35 cap on insulin costs for seniors on Medicare and three pharma companies agreeing to the cost reduction, Amazon is now giving its online customers instant discounts for the diabetes drug.
"Companies are reevaluating their recruitment strategies to adapt to the new reality and appealing to candidates by highlighting their commitment to employee safety, flexible work arrangements and robust support programs," the study concluded.